Medicare Enrolled

Dr. Raymond Lee, M.D.

Hematology & Oncology · San Jose, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
200 JOSE FIGUERES AVE, San Jose, CA 95116
4089233388
In practice since 2005 (20 years)
NPI: 1053317818 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lee? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lee

Dr. Raymond Lee is a hematology & oncology specialist in San Jose, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lee performed 300 Medicare services across 197 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lee received a total of $18,886 from 70 pharmaceutical and/or device companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lee is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 300 Medicare services $18,886 industry payments

Medicare Practice Summary

Medicare Utilization ↗
300
Medicare services
Bottom 25% in CA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
197
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~15 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
 168 $73 $160
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
 96 $110 $213
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
 21 $5 $5
New patient office visit, complex (60-74 min) 15 $175 $335
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$18,886
Total received (2018-2024)
Avg $2,698/year across 7 years
Top 22% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
545
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,441 (65.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,459 (23.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,986 (10.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,858
2023
$2,325
2022
$2,332
2021
$1,696
2020
$2,041
2019
$6,032
2018
$1,602

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$552
Astellas Pharma US Inc
$262
Novartis Pharmaceuticals Corporation
$230
Janssen Biotech, Inc.
$207
PFIZER INC.
$197
Coherus Biosciences Inc.
$147
Merck Sharp & Dohme LLC
$113
Regeneron Healthcare Solutions, Inc.
$97
ABBVIE INC.
$96
ARRAY BIOPHARMA INC
$74
GlaxoSmithKline, LLC.
$73
SOBI, INC
$67
E.R. Squibb & Sons, L.L.C.
$66
Celgene Corporation
$61
Takeda Pharmaceuticals U.S.A., Inc.
$59
PharmaEssentia USA Corporation
$56
PROGENICS PHARMACEUTICALS, INC.
$53
Daiichi Sankyo Inc.
$48
TAIHO ONCOLOGY, INC.
$36
Deciphera Pharmaceuticals Inc.
$36
EMD Serono, Inc.
$34
Stemline Therapeutics Inc.
$34
Bayer Healthcare Pharmaceuticals Inc.
$34
Sumitomo Pharma America, Inc.
$33
Lilly USA, LLC
$30
Genmab U.S., Inc.
$28
Eisai Inc.
$25
Tempus AI, Inc
$25
BeiGene USA, Inc.
$23
Acrotech Biopharma Inc.
$22
Gilead Sciences, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Top 3 companies account for 36.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$6,000
Rigel Pharmaceuticals, Inc.
$1,413
PFIZER INC.
$1,219
E.R. Squibb & Sons, L.L.C.
$1,122
Janssen Biotech, Inc.
$979
Novartis Pharmaceuticals Corporation
$909
Astellas Pharma US Inc
$714
Lilly USA, LLC
$585
Seagen Inc.
$580
Takeda Pharmaceuticals U.S.A., Inc.
$422
Merck Sharp & Dohme LLC
$332
Merck Sharp & Dohme Corporation
$267
GlaxoSmithKline, LLC.
$263
Bayer HealthCare Pharmaceuticals Inc.
$250
Celgene Corporation
$248
Janssen Pharmaceuticals, Inc
$174
Coherus Biosciences Inc.
$147
Amgen Inc.
$144
Daiichi Sankyo Inc.
$136
ARRAY BIOPHARMA INC
$132
Regeneron Healthcare Solutions, Inc.
$129
Alexion Pharmaceuticals, Inc.
$125
ABBVIE INC.
$117
Clovis Oncology, Inc.
$115
EMD Serono, Inc.
$109
Kite Pharma, Inc.
$102
Dova Pharmaceuticals
$102
Amarin Pharma Inc.
$100
Intuitive Surgical, Inc.
$95
Foundation Medicine, Inc.
$91
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Eisai Inc.
$89
Seattle Genetics, Inc.
$79
Janssen Products, LP
$75
Genentech USA, Inc.
$74
Pharmacyclics LLC, An AbbVie Company
$71
Progenics Pharmaceuticals, Inc.
$67
SOBI, INC
$67
Deciphera Pharmaceuticals Inc.
$66
Incyte Corporation
$65
Bayer Healthcare Pharmaceuticals Inc.
$58
Blueprint Medicines Corporation
$58
PharmaEssentia USA Corporation
$56
Sobi, Inc
$54
PROGENICS PHARMACEUTICALS, INC.
$53
Merz North America, Inc.
$52
Gilead Sciences, Inc.
$48
Puma Biotechnology, Inc.
$45
TOLMAR Pharmaceuticals, Inc.
$42
ADC Therapeutics America, Inc.
$39
JAZZ PHARMACEUTICALS INC.
$38
GENZYME CORPORATION
$37
TAIHO ONCOLOGY, INC.
$36
Stemline Therapeutics Inc.
$34
Elekta, Inc.
$34
Sumitomo Pharma America, Inc.
$33
Aveo Pharmaceuticals, Inc.
$32
Genmab U.S., Inc.
$28
CTI BioPharma Corp.
$27
Tempus AI, Inc
$25
EISAI INC.
$25
PUMA BIOTECHNOLOGY, INC.
$24
BeiGene USA, Inc.
$23
Array BioPharma Inc.
$22
Acrotech Biopharma Inc.
$22
Janssen Scientific Affairs, LLC
$21
MorphoSys, US Inc.
$21
Vyera Pharmaceuticals, LLC
$16
Acrotech Biopharma LLC
$14
MEDIVATION FIELD SOLUTIONS LLC
$6
Top 3 companies account for 45.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AYVAKIT · Abraxane · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · Bavencio · Braftovi · CALQUENCE · CYRAMZA · DARZALEX · DOPTELET · Da Vinci Surgical System · Daraprim 30 Tablet in 1 Bottle · Doptelet · ELEKTA UNITY · ELIQUIS · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FENSOLVI · FOTIVDA · FOUNDATIONONE · FRUZAQLA · GAVRETO · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · INREBIC · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LOQTORZI · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Orserdu · PADCEV · PLUVICTO · PROMACTA · PYLARIFY · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYDAPT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SPRYCEL · SUNOSI · TAGRISSO · TALZENNA · TASIGNA · TECVAYLI · TEVIMBRA · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Trodelvy · Udenyca · VELCADE · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vascepa · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XEOMIN · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in San Jose?
Compare hematology & oncology specialists in the San Jose area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
106
Per 100K population
5.6
County median income
$159,674
Nearest hospital
REGIONAL MEDICAL CENTER OF SAN JOSE
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lee is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lee experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Lee performed 168 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lee receive payments from pharmaceutical companies?
Yes. Dr. Lee received a total of $18,886 from 70 companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lee's costs compare to other hematology & oncology specialists in San Jose?
Dr. Lee's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in San Jose
Browse hematology & oncology specialists in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →